deferoxamine has been researched along with Anemia, Hemolytic, Congenital in 9 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Anemia, Hemolytic, Congenital: Hemolytic anemia due to various intrinsic defects of the erythrocyte.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferoxamine was given subcutaneously for 14 months." | 5.26 | Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I. ( Perrault, J; Smithson, WA, 1982) |
| "Deferoxamine is a chelating agent that has extended the life expectancy of patients with thalassemia." | 1.33 | Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients. ( Chen, LJ; Chen, SH; Cheng, SY; Liang, DC; Lin, HC; Liu, HC, 2005) |
| "Deferoxamine was given subcutaneously for 14 months." | 1.26 | Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I. ( Perrault, J; Smithson, WA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assis, RA | 1 |
| Kassab, C | 1 |
| Seguro, FS | 1 |
| Costa, FF | 1 |
| Silveira, PA | 1 |
| Wood, J | 1 |
| Hamerschlak, N | 1 |
| Sözen, M | 1 |
| Karaaslan, C | 1 |
| Oner, R | 1 |
| Gümrük, F | 1 |
| Ozdemir, MA | 1 |
| Altay, C | 1 |
| Gürgey, A | 1 |
| Oner, C | 1 |
| Chen, SH | 1 |
| Liang, DC | 1 |
| Lin, HC | 1 |
| Cheng, SY | 1 |
| Chen, LJ | 1 |
| Liu, HC | 1 |
| Pippard, MJ | 1 |
| Callender, ST | 1 |
| Smithson, WA | 1 |
| Perrault, J | 1 |
| Salem, HH | 1 |
| Van Der Weyden, MB | 1 |
| Firkin, BG | 1 |
| Miyazawa, K | 1 |
| Yoshikawa, O | 1 |
| Takakuwa, Y | 1 |
| Tuda, A | 1 |
| Ohtaka, M | 1 |
| Lin, KY | 1 |
| Iguchi, Y | 1 |
| Naruto, M | 1 |
| Kondo, M | 1 |
| Toyama, K | 1 |
| Wang, WC | 1 |
| Ahmed, N | 1 |
| Hanna, M | 1 |
| Dumont-Senaneuch, C | 1 |
| Floret, D | 1 |
| Philippe, N | 1 |
1 review available for deferoxamine and Anemia, Hemolytic, Congenital
| Article | Year |
|---|---|
[Successful treatment of congenital dyserythropoietic anemia type I with long-term administration of deferoxamine].
Topics: Adult; Anemia, Dyserythropoietic, Congenital; Anemia, Hemolytic, Congenital; Deferoxamine; Drug Eval | 1988 |
8 other studies available for deferoxamine and Anemia, Hemolytic, Congenital
| Article | Year |
|---|---|
Iron overload in a teenager with xerocytosis: the importance of nuclear magnetic resonance imaging.
Topics: Adolescent; Anemia, Hemolytic, Congenital; Chelation Therapy; Deferoxamine; Female; Humans; Hydrops | 2013 |
Severe hemolytic anemia associated with Hb Volga [beta27(B9)Ala-->Asp]: GCC-->GAC at codon 27 in a Turkish family.
Topics: Adult; Anemia, Hemolytic, Congenital; Blood Protein Electrophoresis; Child, Preschool; Codon; Combin | 2004 |
Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Anemia, Hemolytic, Congenital; beta-Thalassemia; Chelat | 2005 |
The management of iron chelation therapy.
Topics: Anemia, Hemolytic, Congenital; Ascorbic Acid; Child; Child, Preschool; Deferoxamine; Drug Administra | 1983 |
Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I.
Topics: Anemia, Dyserythropoietic, Congenital; Anemia, Hemolytic, Congenital; Biopsy; Child; Deferoxamine; F | 1982 |
Iron overload in congenital erythrocyte pyruvate kinase deficiency.
Topics: Adult; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Deferoxamine; Erythrocytes; Hemochromatosis | 1980 |
Non-transferrin-bound iron in long-term transfusion in children with congenital anemias.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Anemia, Sickle Cell; Anemia, Sideroblastic; Bindin | 1986 |
[Fatal Yersinia enterocolitica septic shock in a child with chronic anemia].
Topics: Anemia, Hemolytic, Congenital; Child, Preschool; Deferoxamine; Humans; Male; Risk Factors; Shock, Se | 1988 |